These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 20347641)
21. Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease. Sekine T; Konno M; Sasaki S; Moritani S; Miura T; Wong WS; Nishio H; Nishiguchi T; Ohuchi MY; Tsuchiya S; Matsuyama T; Kanegane H; Ida K; Miura K; Harita Y; Hattori M; Horita S; Igarashi T; Saito H; Kunishima S Kidney Int; 2010 Jul; 78(2):207-14. PubMed ID: 20200500 [TBL] [Abstract][Full Text] [Related]
22. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians. Tayo BO; Kramer H; Salako BL; Gottesman O; McKenzie CA; Ogunniyi A; Bottinger EP; Cooper RS Int Urol Nephrol; 2013 Apr; 45(2):485-94. PubMed ID: 22956460 [TBL] [Abstract][Full Text] [Related]
23. Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism? Kopp JB Kidney Int; 2010 Jul; 78(2):130-3. PubMed ID: 20588287 [TBL] [Abstract][Full Text] [Related]
27. The MYH9/APOL1 region and chronic kidney disease in European-Americans. O'Seaghdha CM; Parekh RS; Hwang SJ; Li M; Köttgen A; Coresh J; Yang Q; Fox CS; Kao WH Hum Mol Genet; 2011 Jun; 20(12):2450-6. PubMed ID: 21429915 [TBL] [Abstract][Full Text] [Related]
28. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease. Kang JS; Lee SJ; Lee JH; Kim JH; Son SS; Cha SK; Lee ES; Chung CH; Lee EY Sci Rep; 2019 May; 9(1):7679. PubMed ID: 31118506 [TBL] [Abstract][Full Text] [Related]
29. Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene. Núñez M; Saran AM; Freedman BI Adv Chronic Kidney Dis; 2010 Jan; 17(1):44-51. PubMed ID: 20005488 [TBL] [Abstract][Full Text] [Related]
30. Background strain and the differential susceptibility of podocyte-specific deletion of Myh9 on murine models of experimental glomerulosclerosis and HIV nephropathy. Johnstone DB; Ikizler O; Zhang J; Holzman LB PLoS One; 2013; 8(7):e67839. PubMed ID: 23874454 [TBL] [Abstract][Full Text] [Related]
31. The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. Freedman BI; Edberg JC; Comeau ME; Murea M; Bowden DW; Divers J; Alarcón GS; Brown EE; McGwin G; Kopp JB; Winkler CA; Nelson GW; Illei G; Petri M; Ramsey-Goldman R; Reveille JD; Vilá LM; Langefeld CD; Kimberly RP; Am J Nephrol; 2010; 32(1):66-72. PubMed ID: 20523037 [TBL] [Abstract][Full Text] [Related]
32. Modulation of podocyte phenotype in collapsing glomerulopathies. Barisoni L; Kopp JB Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394 [TBL] [Abstract][Full Text] [Related]
33. Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation. Freedman BI; Nagaraj SK; Lin JJ; Gautreaux MD; Bowden DW; Iskandar SS; Stratta RJ; Rogers J; Hartmann EL; Farney AC; Reeves-Daniel AM Am J Transplant; 2009 Oct; 9(10):2435-40. PubMed ID: 19764949 [TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in the non-muscle myosin heavy chain gene (MYH9) are associated with lower glomerular filtration rate in mixed ancestry diabetic subjects from South Africa. Matsha TE; Masconi K; Yako YY; Hassan MS; Macharia M; Erasmus RT; Kengne AP PLoS One; 2012; 7(12):e52529. PubMed ID: 23285077 [TBL] [Abstract][Full Text] [Related]
40. Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease. Sun XH; Wang ZY; Yang HY; Cao LJ; Su J; Yu ZQ; Bai X; Ruan CG Acta Haematol; 2013; 129(2):106-13. PubMed ID: 23207509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]